Spanish Diabetes Society (SED) recommendations for the pharmacologic treatment of hyperglycemia in type 2 diabetes: 2018 Update

被引：17

作者：

Gomez-Peralta, Fernando ^{[1
]}

Escalada San Martin, Francisco Javier ^{[2
,3
,4
]}

Menendez Torre, Edelmiro ^{[5
]}

Mata Cases, Manel ^{[6
,7
]}

Ferrer Garcia, Juan Carlos ^{[8
]}

Ezkurra Loiola, Patxi ^{[9
]}

Avila Lachica, Luis ^{[10
]}

Fornos Perez, Jose Antonio ^{[11
]}

Artola Menendez, Sara ^{[12
]}

Alvarez-Guisasola, Fernando ^{[13
]}

Rica Echevarrian, Itxaso ^{[14
]}

Girbes Borras, Juan ^{[15
]}

机构：

[1] Hosp Gen Segovia, Unidad Endocrinol & Nutr, Segovia, Spain

[2] Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Pamplona, Spain

[3] Inst Invest Sanit Navarra IdiSNA, Diabet & Enfermedades Metab, Pamplona, Spain

[4] Clin Univ Navarra, Dept Endocrinol & Nutr, Pamplona, Spain

[5] Hosp Univ Cent Asturias, Serv Endocrinol & Nutr, Oviedo, Spain

[6] CIBER Diabet & Enfermedades Metab Asociadas CIBER, Madrid, Spain

[7] Gerencia Ambit Atencio Primaria Barcelona Ciuta, Ctr Atenc Primaria La Mina, Inst Catala Salut, Barcelona, Spain

[8] Hosp Gen Univ Valencia, Secc Endocrinol & Nutr, Valencia, Spain

[9] Ctr Salud Zumaia, Zumaia, Gipuzkoa, Spain

[10] Ctr Salud Axarquia Oeste, Consultorio Almachar, Malaga, Spain

[11] Grp Berbes Invest & Docencia, Cangas, Pontevedra, Spain

[12] Ctr Salud Jose Marva, Madrid, Spain

[13] Ctr Salud Ribera Orbigo, Leon, Spain

[14] Hosp Univ Cruces, Secc Endocrinol Pediat, Baracaldo, Vizcaya, Spain

[15] Hosp Arnau Vilanova, Serv Endocrinol & Nutr, Valencia, Spain

来源：

ENDOCRINOLOGIA DIABETES Y NUTRICION | 2018年 / 65卷 / 10期

关键词：

Type; 2; diabetes; Treatment; Cost; Complexity; Cardiovascular risk; Hypoglycaemia; Nephroprotection; FIXED-RATIO COMBINATION; CARDIOVASCULAR OUTCOMES; GLYCEMIC CONTROL; INSULIN DEGLUDEC; BASAL INSULIN; METFORMIN; PREVENTION; MANAGEMENT; DISEASE; EMPAGLIFLOZIN;

D O I：

10.1016/j.endinu.2018.08.004

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Type 2 diabetes mellitus (DM2) has become a problem of global dimensions by their high and growing prevalence worldwide and the personal and economic costs associated with it. Correct treatment can reduce mortality and associated complications. New concepts have recently been included in routine clinical practice and have changed the algorithm of DM2 pharmacological therapy. Therefore, the Spanish Society of Diabetes (SED) entrusted to the Working Group of Consensus and Clinical Guidelines an update of the 2010 document Recommendations for Pharmacological Treatment of Hyperglycemia in Diabetes type 2. Novel aspects include nine characteristics to describe each drug group: efficiency, the risk of hypoglycemia, effects on body weight, the demonstrated effect in cardiovascular risk, nephroprotection, limitation of use in renal insufficiency, the rate of secondary effects, complexity and costs. Additionally, the document details combination options, and develop the start and adjustment of available injectable therapies. (C) 2018 SEEN y SED. Published by Elsevier Espana, S.L.U. All rights reserved.

引用

页码：611 / 624

页数：14

共 50 条

[1] Recommendations for the pharmacologic treatment of hyperglycemia in type 2 diabetes
Menendez Torre, E.
Lafita Tejedor, J.
Artola Menendez, S.
Millan Nunez-Cortes, J.
Alonso Garcia, A.
Puig Domingo, M.
Garcia Solans, J. R.
Alvarez Guisasola, F.
Garcia Alegria, J.
Mediavilla Bravo, J.
Miranda Fernandez-Santos, C.
Romero Gonzalez, R.
[J]. AVANCES EN DIABETOLOGIA, 2010, 26 (05): : 331 - 338
[2] RECOMMENDATIONS FOR THE PHARMACOLOGIC TREATMENT OF HYPERGLYCEMIA IN TYPE 2 DIABETES
Menendez Torre, E.
Lafita Tejedor, J.
Artola Menendez, S.
Millan Nunez-Cortes, J.
Alonso Garcia, A.
Puig Domingo, M.
Garcia Solans, J. R.
Alvarez Guisasola, F.
Garcia Alegria, J.
Mediavilla Bravo, J.
Miranda Fernandez-Santos, C.
Romero Gonzalez, R.
[J]. FARMACEUTICOS COMUNITARIOS, 2010, 2 (04): : 154 - 161
[3] Diabetes mellitus and cardiovascular risk: Update of the recommendations of the Diabetes and Cardiovascular Disease working group of the Spanish Diabetes Society (SED, 2018)
Arrieta, Francisco
Iglesias, Pedro
Pedro-Botet, Juan
Becerra, Antonio
Ortega, Emilio
Carlos Obaya, Juan
Nubiola, Andreu
Fernando Maldonado, Gonzalo
del Mar Campos, Maria
Petrecca, Romina
Luis Pardo, Jose
Sanchez-Margalet, Victor
Juan Aleman, Jose
Navarro, Jorge
Duran, Santiago
Javier Tebar, Francisco
Aguilar, Manuel
Escobar, Fernando
[J]. CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2018, 30 (03): : 137 - 153
[4] Diabetes mellitus and cardiovascular risk: an update of the recommendations of the Diabetes and Cardiovascular Disease Working Group of the Spanish Society of Diabetes (SED, 2021)
Arrieta, Francisco
Pedro-Botet, Juan
Iglesias, Pedro
Carlos Obaya, Juan
Montanez, Laura
Fernando Maldonado, Gonzalo
Becerra, Antonio
Navarro, Jorge
Perez, J. C.
Petrecca, Romina
Luis Pardo, Jose
Ribalta, Josep
Sanchez-Margalet, Victor
Duran, Santiago
Javier Tebar, Francisco
Aguilar, Manuel
[J]. CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2022, 34 (01): : 36 - 55
[5] Recommendations for the pharmacological treatment of hyperglycemia in type 2 diabetes
Menendez Torre, Edelmiro
Lafita Tejedor, Francisco Javier
Artola Menendez, Sara
Millan Nunez-Cortes, Jesus
Alonso Garcia, Angeles
Puig Domingo, Manuel
Garcia Solans, Jose Ramon
Alvarez Guisasola, Fernando
Garcia Alegria, Javier
Mediavilla Bravo, Javier
Miranda Fernandez-Santos, Carlos
Romero Gonzalez, Ramon
[J]. CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2011, 23 (01): : 40 - 48
[6] Recommendations for the pharmacological treatment of hyperglycemia in type 2 diabetes
Menendez Torre, E.
Lafita Tejedor, J.
Artola Menendez, S.
Milian Nunez-Cortes, J.
Alonso Garcia, A.
Puig Domingo, M.
Garcia Solans, J. R.
Alvarez Guisasola, F.
Garcia Alegria, J.
Mediavilla Bravo, J.
Miranda Fernandez-Santos, C.
Romero Gonzalez, R.
[J]. REVISTA CLINICA ESPANOLA, 2011, 211 (03): : 147 - 155
[7] CE: Type 2 Diabetes: A Pharmacologic Update
Keresztes, Patricia
Peacock-Johnson, Annette
[J]. AMERICAN JOURNAL OF NURSING, 2019, 119 (03) : 32 - 40
[8] Diabetes mellitus and cardiovascular risk: Working group recommendations of Diabetes and Cardiovascular Disease of the Spanish Society of Diabetes (SED, 2015)
Arrieta, Francisco
Iglesias, Pedro
Pedro-Botet, Juan
Javier Tebar, Francisco
Ortega, Emilio
Nubiola, Andreu
Luis Pardo, Jose
Fernando Maldonado, Gonzalo
Carlos Obaya, Juan
Matute, Pablo
Petrecca, Romina
Alonso, Nuria
Sarabia, Elena
Sanchez-Margalet, Victor
Juan Aleman, Jose
Navarro, Jorge
Becerra, Antonio
Duran, Santiago
Aguilar, Manuel
Escobar-Jimenez, Fernando
[J]. ATENCION PRIMARIA, 2016, 48 (05): : 325 - 336
[9] Recommendations of the Spanish Diabetes Society
Millan Nunez-Cortes, Jesus
Lahera Julia, Vicente
Vazquez Carrera, Manuel
[J]. CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2010, 22 (03): : 113 - 114
[10] Medical treatment of type 2 diabetes mellitus: Recommendations of the Diabetes, Obesity and Nutrition Group of the Spanish Society of Internal Medicine
Carrasco-Sanchez, F. J.
Fernandez-Rodriguez, J. M.
Ena, J.
Gomez-Huelgas, R.
Carretero-Gomez, J.
[J]. REVISTA CLINICA ESPANOLA, 2021, 221 (02): : 101 - 108

← 1 2 3 4 5 →